Viridian Therapeutics, Inc. is a biotechnology company based in Waltham, MA, specializing in the development of optimized treatments for rare autoimmune conditions. Leveraging their core expertise in antibody discovery and engineering, they are dedicated to framing the future of autoimmune diseases by improving patient care through innovative therapeutics.
With a focus on thyroid eye disease (TED) and the FcRn portfolio, Viridian Therapeutics is motivated to make a significant impact in the field of autoimmune diseases. They place the impacts of TED into perspective, offering educational resources and conducting clinical trials to advance their mission of bringing talented and motivated individuals together, empowered to excel in the pursuit of improved patient outcomes.
Generated from the website